Name
OÜ Chemestmed
Registry code
12140551
VAT number
EE101942575
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
29.07.2011 (13)
Financial year
01.01-31.12
Capital
2 500.00 €
Activity
72111 - Research and experimental development on biotechnology
-
0 €
-
-
2 500 €
0
Submitted
No tax arrears
-
-
Owner | Representative | Beneficial owner | Roles | |
---|---|---|---|---|
Mihkel Märtson 03.11.1985 (39) | 100% - 2 500.00 EUR | Board member | Direct ownership | |
Neinar Seli 07.12.1959 (64) | - | Board member | Member of a higher management body, i.e. board member or supervisory board member | |
aktsiaselts RONDAM 10086617 | - | - | - | Founder |
Owner | Representative | Beneficial owner | Roles | |
---|---|---|---|---|
MolCode AS 11081504 | 10% - 4 268.80 EUR | - | - | Shareholder |
2019 17.06.2020 | 2020 16.06.2021 | 2021 16.06.2022 | 2022 20.06.2023 | 2023 17.06.2024 | |
---|---|---|---|---|---|
Total Revenue | - | - | - | - | - |
Net profit (loss) for the period | -844 € | -2 340 € | -1 € | 0 € | 0 € |
Profit Margin | - | - | - | - | - |
Current Assets | 763 006 € | 933 277 € | 1 326 703 € | 1 613 679 € | 2 056 051 € |
Fixed Assets | - | - | - | - | - |
Total Assets | 763 006 € | 933 277 € | 1 326 703 € | 1 613 679 € | 2 056 051 € |
Current Liabilities | 20 165 € | 37 776 € | 121 203 € | 108 179 € | 130 551 € |
Non Current Liabilities | 738 000 € | 893 000 € | 1 203 000 € | 1 503 000 € | 1 923 000 € |
Total Liabilities | 758 165 € | 930 776 € | 1 324 203 € | 1 611 179 € | 2 053 551 € |
Share Capital | - | - | - | - | - |
Equity | 4 841 € | 2 501 € | 2 500 € | 2 500 € | 2 500 € |
Employees | 0 | 0 | 0 | 0 | 0 |
Turnover | State taxes | Labor taxes and payments | Employees | |
---|---|---|---|---|
2024 Q1 | - | - | 935.67 € | 1 |
2023 Q4 | - | - | - | 1 |
2023 Q3 | - | - | - | - |
2023 Q2 | - | - | - | - |
2023 Q1 | - | - | - | - |
2022 Q4 | - | - | - | - |
2022 Q3 | - | - | - | - |
2022 Q2 | - | - | - | - |
2022 Q1 | - | - | - | - |
2021 Q4 | 15 169 € | - | - | - |
2021 Q3 | - | - | - | - |
2021 Q2 | - | - | - | - |
2021 Q1 | - | - | - | - |
2020 Q4 | - | - | - | - |
2020 Q3 | - | - | - | - |
2020 Q2 | - | - | - | - |
2020 Q1 | - | - | - | - |